- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-28-0008295

Shiro Pharmachem Private Limited
About Shiro Pharmachem Private Limited
Data last updated:
Shiro Pharmachem Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 27 November 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2012PTC238300. Its GSTIN is 27AASCS3584L1ZG (Maharashtra).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Balvant Murlidhar Parchure and Nupura Balvant Parchure.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1901/B Wing Pride Presedency Luxuria, Nr Pride Park Opp Lawkim Co. G.B. Road Thane, Maharashtra, India – 400607.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.99 Lakh, a decline of 39% compared to the previous year. For the same year it recorded a net loss of ₹11.17 Lakh (net margin -186.4%) and EBITDA of -₹9.65 Lakh (EBITDA margin -161%). Revenue has declined at a compounded annual rate (CAGR) of 5% over five years.
As per MCA filings, the company has open charges of ₹68.92 Lakh on record.
Shiro Pharmachem Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-28-0008295). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Shiro Pharmachem
Contact details
Shiro Pharmachem Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1901/B Wing Pride Presedency Luxuria, Nr Pride Park Opp Lawkim Co. G.B. Road Thane, Maharashtra, India – 400607
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Shiro Pharmachem Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Shiro Pharmachem is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Shiro Pharmachem Private Limited, buy the company report.
Financials of Shiro Pharmachem Private Limited
FY 2025 filings availableShiro Pharmachem Private Limited reported revenue of ₹5.99 Lakh (down 39% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 5% over five years, including a 39% fall in the latest year. EBITDA fell 405% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹9.65 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹11.17 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -161% | ||||
| Net Profit Margin | -186.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shiro Pharmachem Private Limited, buy the company report.
Board of directors of Shiro Pharmachem Private Limited
Shiro Pharmachem has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Balvant Murlidhar Parchure Also directs: Acros Pharma Chem Private Limited | Director | 22 Apr 2014 | 12 Years 6 Months | Current |
| Nupura Balvant Parchure Also directs: Greenovate Fuels Private Limited | Director | 27 Nov 2012 | 13 Years 11 Months | Current |
Auditor
Shiro Pharmachem Private Limited is audited by Nandarshi Bhatt & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Nandarshi Bhatt & Associates | FY 2023 | 134329W |
Shareholding
The shareholding of Shiro Pharmachem Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Shiro Pharmachem Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Oct 2025 | 101185680 | Others | ₹25 Lakh | Open | |
| 31 Mar 2022 | 100563302 | Bank of India | ₹2 Lakh | Open | |
| 07 Jan 2022 | 100523144 | Bank of India | ₹6.92 Lakh | Open | |
| 19 Jan 2018 | 100154678 | Bank of India | ₹3 Lakh | Open | |
| 19 Jan 2018 | 100154679 | Bank of India | ₹32 Lakh | Open |
Total charge records: 5 View all charges
Legal cases
No court or tribunal cases involving Shiro Pharmachem Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Shiro Pharmachem Private Limited has 6 MSME Form 1 returns on record between 2019 and 2022, listing 11 overdue payments to 7 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 7)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Nandarshi Bhatt & Associates | |||
| an individual supplier | |||
| an individual supplier | |||
| Witmans Industries Private Limited |
To see the full MSME payment records of Shiro Pharmachem Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Shiro Pharmachem has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AASCS3584L1ZG | Maharashtra | Active | 23 Nov 2017 |
To see the full GST registrations and return filing status of Shiro Pharmachem Private Limited, buy the company report.
Recent activity
Shiro Pharmachem Private Limited has 3 board changes on record since 2012: 2 appointments and 1 cessation. The latest: Madhura Koustubh Joshi ceased to be Director on 14 May 2014.
Frequently asked questions
Shiro Pharmachem is an active private limited company based in Thane, Maharashtra, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 27 November 2012 (14+ years old) and is registered under CIN U24233MH2012PTC238300.
Shiro Pharmachem has 2 current directors:
- Balvant Murlidhar Parchure - Director
- Nupura Balvant Parchure - Director
The latest financial statements of Shiro Pharmachem on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Shiro Pharmachem is 27AASCS3584L1ZG, registered in Maharashtra.
The CIN (Corporate Identification Number) of Shiro Pharmachem is U24233MH2012PTC238300. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shiro Pharmachem was incorporated on 27 November 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
Madhura Koustubh Joshi ceased to be Director on 14 May 2014. Balvant Murlidhar Parchure was appointed as Director on 22 Apr 2014. Nupura Balvant Parchure was appointed as Director on 27 Nov 2012.
Yes, Shiro Pharmachem is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-28-0008295).
Shiro Pharmachem has 6 MSME Form 1 returns on record between 2019 and 2022, listing 11 overdue payments to 7 micro and small suppliers. The latest return was filed on 22 Jun 2022.
The registered office of Shiro Pharmachem is at 1901B Wing Pride Presedency Luxuria, Nr Pride Park Opp Lawkim Co. G.B. Road Thane, Maharashtra, India – 400607.
Shiro Pharmachem operates in the chemicals and materials industry, in the industrial chemicals segment.